Gene · 9112
Papers2,013
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,013
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Brain Cell Type-Specific Nuclear Proteomics Is Imperative to Resolve Neurodegenerative Disease Mechanisms. | Front Neurosci | 2022 | 35784845 | PubTator, text mining | PubMed |
| The role of epigenetic modifications in drug resistance and treatment of breast cancer. | Cell Mol Biol Lett | 2022 | 35764927 | PubTator, text mining | PubMed |
| MTA1 aggravates experimental colitis in mice by promoting transcription factor HIF1A and up-regulating AQP4 expression. | Cell Death Discov | 2022 | 35764613 | PubTator, text mining | PubMed |
| LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription. | Exp Mol Med | 2022 | 35760875 | PubTator, text mining | PubMed |
| The Novel lncRNA ENST00000530525 Affects ANO1, Contributing to Blood-Brain Barrier Injury in Cultured hCMEC/D3 Cells Under OGD/R Conditions. | Front Genet | 2022 | 35754821 | PubTator, text mining | PubMed |
| Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies. | Front Oncol | 2022 | 35719973 | PubTator, text mining | PubMed |
| The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer. | NPJ Precis Oncol | 2022 | 35715489 | PubTator, text mining | PubMed |
| A Photo-Crosslinking Approach to Identify Class II SUMO-1 Binders. | Front Chem | 2022 | 35707458 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Targeting Mechanisms of the DNA Damage Response (DDR) and DNA Repair by Natural Compounds to Improve cAT-Triggered Tumor Cell Death. | Molecules | 2022 | 35684504 | PubTator, text mining | PubMed |
| The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders. | Int J Mol Sci | 2022 | 35682599 | PubTator, text mining | PubMed |
| Potential Prognostic Markers for Relapsed/Refractory vs. Responsive Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 35681732 | PubTator, text mining | PubMed |
| Structural basis for MTA1c-mediated DNA N6-adenine methylation. | Nat Commun | 2022 | 35672411 | PubTator, text mining | PubMed |
| Systems-Level Mapping of Cancer Testis Antigen 1b/a to Sarcoma Pathways Identifies Activated Ran Binding-2 E3 SUMO-Protein Ligase and Transducin-Like Enhancer Protein 1. | Front Genet | 2022 | 35664317 | PubTator, text mining | PubMed |
| Characteristics of miRNAs Present in Bovine Sperm and Associations With Differences in Fertility. | Front Endocrinol (Lausanne) | 2022 | 35663333 | PubTator, text mining | PubMed |
| Comprehensive competitive endogenous RNA network analysis reveals EZH2-related axes and prognostic biomarkers in hepatocellular carcinoma. | Iran J Basic Med Sci | 2022 | 35656182 | PubTator, text mining | PubMed |
| miR-30 inhibits the progression of osteosarcoma by targeting MTA1. | J Musculoskelet Neuronal Interact | 2022 | 35642705 | PubTator, text mining | PubMed |
| The Advances in Epigenetics for Cancer Radiotherapy. | Int J Mol Sci | 2022 | 35628460 | PubTator, text mining | PubMed |
| An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancer. | BMC Pulm Med | 2022 | 35619108 | PubTator, text mining | PubMed |
| Curcumin Inhibits the Growth and Metastasis of Melanoma via miR-222-3p/SOX10/Notch Axis. | Dis Markers | 2022 | 35585935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9112/papers?page=19